UPSC to Interview for Position of Next Drug Controller General of India
Next Week The Union public service commission (UPSC) will be interview for appointment of india’s next Position of Drug Controller General of India. Union Health Ministry to the commission include…
DCGI Recommends Covovax As Heterologous Booster Dose
New Delhi : The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market authorisation for Serum Institute of India’s Covid vaccine Covovax as a heterologous booster dose…
S Eswara Reddy rejoins as joint drug controller after Centre revokes suspension
After the Union government revoked his suspension on December 26, former Joint Drug Controller S Eswara Reddy has rejoined the apex drug regulatory body. The Delhi High Court granted bail…
DCGI: Fourfold increase in Investigational New Drugs Applications in India
New Delhi: Claiming that India is on course to become a ‘global hub for medicines’, Dr VG Somani, Drug Controller General of India (DCGI), said that there has been a fourfold increase in…
Applications are invited for the post of Drugs Controller General (India), CDSCO
Central Drug Testing Laboratory is one of the Seven National Laboratories in India engaged in the research and analysis of Drug and Cosmetics as per Drug and Cosmetics Act, 1940.…
Bharat Bitoech is waiting for DCGI nod for children’s C-19 Vaccine
Bharat Biotech’s Chairman and Managing Director, Dr. Krishna Ella said that they are awaiting approval from the Drug Controller General of India (DCGI) for a C-19 vaccine for children. He said their vaccines…
Antibody Cocktail COVID Therapy, The Party begins at Sir Ganga Ram
New Delhi: Sir Ganga Ram Hospital has commenced administration of Monoclonal Antibody Cocktail (MAC) from 01 June 2021, a combination of Casirivimab & Imdevimab to consenting patients with mild &…
Bharat Parenterals gets DCGI nod for Favipiravir oral suspension
Drug firm Bharat Parenterals on Saturday said it has received approval from the Drugs Controller General of India (DCGI) for favipiravir oral suspension, to be used for treatment of Covid-19 patients. The company has received licence…
Optimus Pharma gets DCGI nod for Phase III trials of Molnupiravir
Optimus Pharma received DCGI nod for conducting Phase III clinical trials for orally administered Molnupiravir capsules on patients with mild to moderate C-19 patients. After developing the active pharma ingredient (API) and the formulations for the product, Optimus…
J&J in discussions with Indian Govt single dose vaccine trial
Johnson & Johnson is in talks with India’s government to begin a clinical trial of its single-dose C-19 vaccine in the country, the company said on Friday. The company’s vaccine is currently approved…
